Your CTCL or related skin lymphoma tissue samples study
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have CTCL, Sézary syndrome, or lymphomatoid papulosis, and you’re starting or changing treatment
- You can give informed consent (sign the study consent form)
- If you have Sézary syndrome or stage IVB CTCL, you meet specific blood test cutoffs
- You’re not currently pregnant
- No history of other lymphoma (for patients), and no HIV history (for control participants)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.
This study looks at why skin lymphomas behave differently from person to person and may identify new targets for treatment. You may be invited if you have (or are being evaluated for) a suspected or confirmed skin lymphoma.
This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.
This study collects leftover tissue samples from patients with or without lymphoma to help researchers better understand lymph system cancers. It may be an option if you are already having a biopsy or surgery.
This trial looks at the results of different systemic (whole-body) treatments for cutaneous T-cell lymphoma (CTCL), a rare type of lymphoma that affects the skin. It aims to understand how well these therapies work and help guide future treatment choices.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
Hear when a new Lymphomatoid Papulosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.